Characterization of four vaccine-related polioviruses including two intertypic type 3/type 2 recombinants associated with aseptic encephalitis
- PMID: 27677968
- PMCID: PMC5039789
- DOI: 10.1186/s12985-016-0615-2
Characterization of four vaccine-related polioviruses including two intertypic type 3/type 2 recombinants associated with aseptic encephalitis
Abstract
Background: Four vaccine-related polioviruses (VRPV) were isolated from aseptic encephalitis cases in Yunnan, China in 2010. The genomic sequences of these VRPVs were investigated to gain a better understanding of their molecular characteristics.
Methods: Molecular typing was performed by amplification and sequencing of the VP1 region. The genomic sequences of the four VRPV3 strains were compared to vaccine strain and wild strain sequences to study genetic drift and recombination.
Results: All four isolates could be entirely neutralized by polyclonal poliovirus 3 (PV3) antisera but not by PV1 and PV2 antisera and displayed a temperature-sensitive phenotype. The genomic sequences of all four isolates contained two Sabin 3-specific attenuating mutations at nucleotides 472(C → T) and 2034(C → T), but a third Sabin 3-specific attenuating mutation at position 2493 (T → C) had reverted back to a T. Recombination analyses showed RF108/YN/CHN/2010 and RF134/YN/CHN/2010 strain recombined with Sabin 2 at the 3'-end of the 2C to 3'-untranslated region (3'-UTR) and at the 5'-end of the 3D to 3'-UTR, respectively.
Conclusion: Four VRPV3 strains including two type 3/type 2 intertypic recombinants were identified. The recombination of Sabin vaccine strains with other Sabin serotypes or human enterovirus C species could be a critical factor in the potential of emerging viruses and related disease outbreaks. Therefore, it is essential to be persistent in the surveillance of EVs (including PV).
Keywords: Aseptic encephalitis; Intertypic recombinant; Vaccine-related polioviruses (VRPVs).
Figures


Similar articles
-
Natural type 3/type 2 intertypic vaccine-related poliovirus recombinants with the first crossover sites within the VP1 capsid coding region.PLoS One. 2010 Dec 21;5(12):e15300. doi: 10.1371/journal.pone.0015300. PLoS One. 2010. PMID: 21203565 Free PMC article.
-
[Genetic characterization of poliovirus isolates from environmental sewage surveillance in Shandong, 2010].Bing Du Xue Bao. 2011 Jul;27(4):337-41. Bing Du Xue Bao. 2011. PMID: 21874902 Chinese.
-
Serial recombination during circulation of type 1 wild-vaccine recombinant polioviruses in China.J Virol. 2003 Oct;77(20):10994-1005. doi: 10.1128/jvi.77.20.10994-11005.2003. J Virol. 2003. PMID: 14512548 Free PMC article.
-
Recurrent isolation of poliovirus 3 strains with chimeric capsid protein Vp1 suggests a recombination hot-spot site in Vp1.Virus Res. 2010 Aug;151(2):246-51. doi: 10.1016/j.virusres.2010.05.006. Epub 2010 May 21. Virus Res. 2010. PMID: 20493912
-
Genomic modifications in Sabin vaccine strains isolated from vaccination-associated cases, healthy contacts and healthy vaccinees.Acta Virol. 1996 Jun;40(3):157-70. Acta Virol. 1996. PMID: 8891097 Review.
Cited by
-
Exploratory re-encoding of yellow fever virus genome: new insights for the design of live-attenuated viruses.Virus Evol. 2018 Jul 23;4(2):vey021. doi: 10.1093/ve/vey021. eCollection 2018 Jul. Virus Evol. 2018. PMID: 30057792 Free PMC article.
References
-
- Arita M, Zhu SL, Yoshida H, Yoneyama T, Miyamura T, Shimizu H. A Sabin 3-derived poliovirus recombinant contained a sequence homologous with indigenous human enterovirus species C in the viral polymerase coding region. J Virol. 2005;79(20):12650–12657. doi: 10.1128/JVI.79.20.12650-12657.2005. - DOI - PMC - PubMed
-
- Rakoto-Andrianarivelo M, Gumede N, Jegouic S, Balanant J, Andriamamonjy SN, Rabemanantsoa S, Birmingham M, Randriamanalina B, Nkolomoni L, Venter M, et al. Reemergence of recombinant vaccine-derived poliovirus outbreak in Madagascar. J Infect Dis. 2008;197(10):1427–1435. doi: 10.1086/587694. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources